New Zealand markets closed

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7018+0.0006 (+0.09%)
At close: 04:00PM EDT
0.7100 +0.01 (+1.17%)
After hours: 07:35PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-44,220
-47,919
-46,180
-42,292
-29,539
Depreciation & amortisation
70
70
74
68
36
Stock-based compensation
3,626
4,622
3,631
3,958
755
Change in working capital
280
10,356
1,132
1,955
1,163
Accounts payable
1,906
1,906
-1,397
-805
-
Other working capital
-39,758
-33,282
-41,691
-35,970
-27,593
Other non-cash items
330
230
-395
313
66
Net cash provided by operating activities
-39,744
-33,275
-41,683
-35,877
-27,519
Cash flows from investing activities
Investments in property, plant and equipment
-14
-7
-8
-93
-74
Purchases of investments
-39,846
-11,881
-36,800
-79,075
0
Sales/maturities of investments
67,665
67,665
60,500
0
-
Net cash used for investing activities
3,140
55,777
23,692
-79,168
-74
Cash flows from financing activities
Debt repayment
0
-1,622
0
-4,770
-
Common stock issued
53,616
53,616
0
0
93,351
Other financing activities
-3,032
-3,032
-319
-39
-2,904
Net cash used provided by (used for) financing activities
-110
49,140
-241
643
181,035
Net change in cash
-36,714
71,642
-18,232
-114,402
153,442
Cash at beginning of period
58,579
24,732
42,964
157,366
3,924
Cash at end of period
21,865
96,374
24,732
42,964
157,366
Free cash flow
Operating cash flow
-39,744
-33,275
-41,683
-35,877
-27,519
Capital expenditure
-14
-7
-8
-93
-74
Free cash flow
-39,758
-33,282
-41,691
-35,970
-27,593